tiprankstipranks
Basilea Pharmaceutica (CH:BSLN)
:BSLN

Compare Basilea Pharmaceutica (BSLN) vs. Competitors

7 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Basilea Pharmaceutica
CHF52.60
CHF649.42M
16.63
30.32%
1 Buy
0 Hold
0 Sell
Moderate Buy
Molecular Partners AG
CHF3.41
CHF134.85M
-2.50
4.05%
1 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF3.41
CHF885.27M
-8.17
262.69%
2 Buy
0 Hold
0 Sell
Moderate Buy
Kuros Biosciences
CHF28.16
CHF930.30M
498.59
31.89%
1 Buy
0 Hold
0 Sell
Moderate Buy
Newron Pharmaceuticals SpA
CHF14.94
CHF310.84M
-9.69
113.73%
1 Buy
0 Hold
0 Sell
Moderate Buy
Santhera Pharmaceuticals Holding
CHF15.74
CHF236.25M
-0.98
26.44%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CH:BSLN
Basilea Pharmaceutica
53.30
13.40
33.58%
CH:MOLN
Molecular Partners AG
3.34
0.30
9.87%
CH:IDIA
Idorsia Ltd
3.50
2.49
246.53%
CH:KURN
Kuros Biosciences
23.70
7.30
44.51%
CH:NWRN
Newron Pharmaceuticals SpA
14.94
8.77
142.14%
CH:SANN
Santhera Pharmaceuticals Holding
16.64
3.94
31.02%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts